JP2011511805A5 - - Google Patents

Download PDF

Info

Publication number
JP2011511805A5
JP2011511805A5 JP2010546063A JP2010546063A JP2011511805A5 JP 2011511805 A5 JP2011511805 A5 JP 2011511805A5 JP 2010546063 A JP2010546063 A JP 2010546063A JP 2010546063 A JP2010546063 A JP 2010546063A JP 2011511805 A5 JP2011511805 A5 JP 2011511805A5
Authority
JP
Japan
Prior art keywords
dmt
phe
lys
arg
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010546063A
Other languages
English (en)
Japanese (ja)
Other versions
JP5453320B2 (ja
JP2011511805A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/033440 external-priority patent/WO2009100363A2/en
Publication of JP2011511805A publication Critical patent/JP2011511805A/ja
Publication of JP2011511805A5 publication Critical patent/JP2011511805A5/ja
Application granted granted Critical
Publication of JP5453320B2 publication Critical patent/JP5453320B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010546063A 2008-02-07 2009-02-06 インスリン抵抗性を防止または処置するための方法 Active JP5453320B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2688208P 2008-02-07 2008-02-07
US61/026,882 2008-02-07
PCT/US2009/033440 WO2009100363A2 (en) 2008-02-07 2009-02-06 Methods for preventing or treating insulin resistance

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014000640A Division JP2014065738A (ja) 2008-02-07 2014-01-06 インスリン抵抗性を防止または処置するための方法

Publications (3)

Publication Number Publication Date
JP2011511805A JP2011511805A (ja) 2011-04-14
JP2011511805A5 true JP2011511805A5 (https=) 2012-03-22
JP5453320B2 JP5453320B2 (ja) 2014-03-26

Family

ID=40952720

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2010546063A Active JP5453320B2 (ja) 2008-02-07 2009-02-06 インスリン抵抗性を防止または処置するための方法
JP2014000640A Withdrawn JP2014065738A (ja) 2008-02-07 2014-01-06 インスリン抵抗性を防止または処置するための方法
JP2015141367A Withdrawn JP2015227353A (ja) 2008-02-07 2015-07-15 インスリン抵抗性を防止または処置するための方法
JP2016247623A Withdrawn JP2017052801A (ja) 2008-02-07 2016-12-21 インスリン抵抗性を防止または処置するための方法
JP2018033123A Pending JP2018090620A (ja) 2008-02-07 2018-02-27 インスリン抵抗性を防止または処置するための方法
JP2019113087A Pending JP2019167384A (ja) 2008-02-07 2019-06-18 インスリン抵抗性を防止または処置するための方法

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2014000640A Withdrawn JP2014065738A (ja) 2008-02-07 2014-01-06 インスリン抵抗性を防止または処置するための方法
JP2015141367A Withdrawn JP2015227353A (ja) 2008-02-07 2015-07-15 インスリン抵抗性を防止または処置するための方法
JP2016247623A Withdrawn JP2017052801A (ja) 2008-02-07 2016-12-21 インスリン抵抗性を防止または処置するための方法
JP2018033123A Pending JP2018090620A (ja) 2008-02-07 2018-02-27 インスリン抵抗性を防止または処置するための方法
JP2019113087A Pending JP2019167384A (ja) 2008-02-07 2019-06-18 インスリン抵抗性を防止または処置するための方法

Country Status (12)

Country Link
US (7) US8088727B2 (https=)
EP (7) EP3103467A1 (https=)
JP (6) JP5453320B2 (https=)
CN (2) CN104107417B (https=)
CA (1) CA2713150C (https=)
CY (1) CY1115305T1 (https=)
DK (1) DK2252312T3 (https=)
ES (1) ES2458870T3 (https=)
PL (1) PL2252312T3 (https=)
PT (1) PT2252312E (https=)
SI (1) SI2252312T1 (https=)
WO (1) WO2009100363A2 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4879020B2 (ja) * 2003-05-01 2012-02-15 コーネル リサーチ ファウンデイション インコーポレイテッド 細胞に分子を送達する方法及び担体複合体
CA2947335A1 (en) * 2005-09-16 2007-03-29 Cornell Research Foundation, Inc. Methods for reducing cd36 expression
EP3103467A1 (en) * 2008-02-07 2016-12-14 Cornell University Methods for preventing or treating insulin resistance
EP3563862B1 (en) 2009-03-20 2021-05-05 The General Hospital Corporation d/b/a Massachusetts General Hospital D-arg-2'6'-dimethyltyrosine-lys-phe-nh2 for use in the prevention of secondary complications of burn injuries
CN105031605A (zh) * 2009-08-12 2015-11-11 康奈尔大学 预防或治疗代谢综合症的方法
PL2470191T3 (pl) * 2009-08-24 2014-09-30 Stealth Peptides Int Inc Sposoby i kompozycje do profilaktyki lub leczenia stanów okulistycznych
EP2485749A4 (en) * 2009-10-05 2013-07-24 Univ Cornell METHOD FOR THE PREVENTION AND TREATMENT OF HEART FAILURE
EP3266462A1 (en) * 2009-12-31 2018-01-10 Stealth Peptides International, Inc. Methods for performing a coronary artery bypass graft procedure
AU2011207432A1 (en) * 2010-01-25 2012-08-02 Cornell University Aromatic-cationic peptides and uses of same
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
GB201018125D0 (en) * 2010-10-26 2010-12-08 Marealis As Peptide
EP3009141A1 (en) * 2011-12-09 2016-04-20 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
HK1204988A1 (en) * 2012-02-22 2015-12-11 Stealth Peptides International, Inc. Methods and compositions for preventing or treating ophthalmic conditions
JP6317324B2 (ja) * 2012-03-30 2018-04-25 ステルス ペプチドズ インターナショナル インコーポレイテッド 神経障害を予防および処置するための方法および組成物
HK1210953A1 (en) * 2012-08-02 2016-05-13 Stealth Peptides International, Inc. Methods for treatment of atherosclerosis
EP2928562A4 (en) * 2012-12-06 2016-06-22 Stealth Peptides Int Inc PEPTIDE THERAPEUTIC PRODUCTS AND METHODS OF USE
MX392555B (es) 2016-09-07 2025-03-24 Univ Temple Composiciones y métodos para el tratamiento de resistencia a la insulina.
BR112020018010A2 (pt) * 2018-03-07 2020-12-29 Temple University - Of The Commonwealth System Of Higher Education Métodos de prevenção ou tratamento de diabetes tipo 2, de prevenção ou tratamento de pré-diabetes e de prevenção ou tratamento de uma condição em um indivíduo em necessidade
EP3761985A4 (en) * 2018-03-07 2021-12-29 Temple University - Of The Commonwealth System of Higher Education Compositions and methods for treatment of insulin resistance
TW202206062A (zh) 2020-04-24 2022-02-16 美國坦普大學 高等教育聯邦系統 治療非酒精性脂肪肝炎的方法
CA3191819A1 (en) 2020-09-09 2022-03-17 Hazel Szeto Methods and compositions for delivery of biotin to mitochondria
CN117881411A (zh) 2021-06-01 2024-04-12 艾迪雅生物有限责任公司 用于眼部药物的延长释放药物递送系统和使用方法
US20240122884A1 (en) * 2022-10-03 2024-04-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of n-lactoyl-phenylalanine and other n-lactoyl-amino acids

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4391904A (en) 1979-12-26 1983-07-05 Syva Company Test strip kits in immunoassays and compositions therein
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5602100A (en) 1988-06-30 1997-02-11 Astra Ab Dermorphin analogs having pharmacological activity
EP0350221B1 (en) 1988-06-30 1996-04-17 Astra Aktiebolag Dermorphin analogs, their methods of preparation, pharmaceutical compositions, and methods of therapeutic treatment using the same
US5670617A (en) 1989-12-21 1997-09-23 Biogen Inc Nucleic acid conjugates of tat-derived transport polypeptides
US5858784A (en) 1991-12-17 1999-01-12 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol- and liposome-based delivery
US5716644A (en) 1992-06-11 1998-02-10 Alkermes, Inc. Composition for sustained release of non-aggregated erythropoietin
US5674534A (en) 1992-06-11 1997-10-07 Alkermes, Inc. Composition for sustained release of non-aggregated erythropoietin
IS4261A (is) 1994-02-21 1995-08-22 Astra Aktiebolag Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra
ATE255450T1 (de) 1995-06-09 2003-12-15 Hisamitsu Pharmaceutical Co Matrix für iontophorese
US5849761A (en) 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US5885958A (en) 1997-03-25 1999-03-23 Administrators Of The Tulane Educational Fund Mu-opiate receptor peptides
US5989463A (en) 1997-09-24 1999-11-23 Alkermes Controlled Therapeutics, Inc. Methods for fabricating polymer-based controlled release devices
CA2314267A1 (en) 1997-12-10 1999-06-17 Washington University Anti-pathogen system and methods of use thereof
JP2002512954A (ja) 1998-04-24 2002-05-08 マイトコー ミトコンドリア関連疾患を処置するための化合物および方法
AU5142699A (en) * 1998-07-31 2000-02-28 Mount Sinai Hospital Corporation Methods and compositions for increasing insulin sensitivity
US6245740B1 (en) 1998-12-23 2001-06-12 Amgen Inc. Polyol:oil suspensions for the sustained release of proteins
SE9900961D0 (sv) 1999-03-16 1999-03-16 Astra Ab Novel compounds
AU7855900A (en) 1999-10-04 2001-05-10 University Of Medicine And Dentistry Of New Jersey Methods for identifying rna binding compounds
US6759520B1 (en) 1999-10-28 2004-07-06 The New England Medical Center Hospitals, Inc. Chimeric analgesic peptides
US20050192215A1 (en) 2000-01-21 2005-09-01 Malabika Ghosh Methods and materials relating to novel polypeptides and polynucleotides
EP1303186B1 (en) 2000-07-18 2011-01-26 Cornell Research Foundation, Inc. Medicinal uses of mu-opioid receptor agonists
US6900178B2 (en) 2000-09-12 2005-05-31 University Of Kentucky Research Foundation Protection against ischemia and reperfusion injury
US20070015146A1 (en) 2001-05-22 2007-01-18 Gene Logic, Inc. Molecular nephrotoxicology modeling
SI2656854T1 (sl) 2003-02-04 2015-09-30 Cornell Research Foundation, Inc. Uporabe aromatsko-kationskega peptida
JP4879020B2 (ja) 2003-05-01 2012-02-15 コーネル リサーチ ファウンデイション インコーポレイテッド 細胞に分子を送達する方法及び担体複合体
US7232824B2 (en) 2003-09-30 2007-06-19 Scios, Inc. Quinazoline derivatives as medicaments
CA2851972C (en) 2004-01-23 2015-06-23 Cornell Research Foundation, Inc. Methods for reducing oxidative damage
US20050272101A1 (en) 2004-06-07 2005-12-08 Prasad Devarajan Method for the early detection of renal injury
CA2947335A1 (en) 2005-09-16 2007-03-29 Cornell Research Foundation, Inc. Methods for reducing cd36 expression
US20070259377A1 (en) * 2005-10-11 2007-11-08 Mickey Urdea Diabetes-associated markers and methods of use thereof
US20080027082A1 (en) 2006-06-19 2008-01-31 Berthold Hocher Use of adenosine a1 antagonists in radiocontrast media induced nephropathy
EP3103467A1 (en) * 2008-02-07 2016-12-14 Cornell University Methods for preventing or treating insulin resistance

Similar Documents

Publication Publication Date Title
JP2011511805A5 (https=)
JP2007527914A5 (https=)
JP2009039101A5 (https=)
JP2010525055A5 (https=)
JP2009256391A5 (https=)
NL300871I2 (nl) ixazomib en farmaceutisch aanvaardbare zouten en esters daarvan, zoals ixazomibcitraat
JP2011513241A5 (https=)
IL210589A (en) C2386RV Protein Tuberculosis Kvfb Protein Use for the Treatment or Prevention of TB
JP2013525444A5 (https=)
JP2012526215A5 (https=)
EP2323719A4 (en) RELEASE OF HIGHLY CONCENTRATED STAIN OXIDE
EP2337569A4 (en) COMPOSITIONS AND METHODS FOR CHARACTERIZING AND RESTORING THE STOMACH DARM, SKIN AND NOSE MICROBIOTA
JP2012502885A5 (https=)
JP2015504870A5 (https=)
EA201100621A1 (ru) Лечение диабета у пациентов, у которых наблюдается недостаточный гликемический контроль несмотря на лечение пероральным или непероральным противодиабетическим лекарственным средством
PL2061485T3 (pl) Peptydy EV576 do zastosowania w leczeniu zespołu Guillaina-Barrégo
JP2012507294A5 (https=)
PL2442814T3 (pl) Bifidobacteria do leczenia cukrzycy i pokrewnych chorób
DK2068889T3 (da) Anakinra til anvendelse i behandling af bronchiolitis obliterans syndrom
JP2014530220A5 (https=)
DK2227243T3 (da) Farmaceutisk sammensætning til behandling af obesitet relaterede sygdomme, omfattende et insulinotropisk peptidkonjugat
BRPI0815577A2 (pt) Peptídeo foxm1 e agente medicinal compreendendo o mesmo.
CL2008001126A1 (es) Compuestos derivados de pirimidinona condensada con heterociclos; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como diabetes, sindrome metabolico y obesidad.
JP2010534684A5 (https=)
JP2014530840A5 (https=)